BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28065631)

  • 1. The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Dig Liver Dis; 2017 May; 49(5):557-561. PubMed ID: 28065631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
    Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
    Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy.
    Kim NH; Jung YS; Lim JW; Park JH; Park DI; Sohn CI
    Gastrointest Endosc; 2019 May; 89(5):1037-1043. PubMed ID: 30684602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Gastrointest Endosc; 2017 Nov; 86(5):892-899. PubMed ID: 28385585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
    Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
    Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men.
    Kim NH; Lee MY; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Yonsei Med J; 2017 Sep; 58(5):910-917. PubMed ID: 28792133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
    Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
    J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Age on the Risk of Advanced Colorectal Neoplasia in a Young Population: An Analysis Using the Predicted Probability Model.
    Jung YS; Park CH; Kim NH; Lee MY; Park DI
    Dig Dis Sci; 2017 Sep; 62(9):2518-2525. PubMed ID: 28733868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Wieten E; de Klerk CM; van der Steen A; Ramakers CR; Kuipers EJ; Hansen BE; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1392-1399.e5. PubMed ID: 30055170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test?
    Kim NH; Yang HJ; Park SK; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Dig Dis Sci; 2016 Sep; 61(9):2685-93. PubMed ID: 27107865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
    Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
    [No Abstract]   [Full Text] [Related]  

  • 18. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
    Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
    Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    PLoS One; 2018; 13(1):e0191125. PubMed ID: 29324874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.
    Auge JM; Fraser CG; Rodriguez C; Roset A; Lopez-Ceron M; Grau J; Castells A; Jimenez W
    Clin Chem Lab Med; 2016 Jan; 54(1):125-32. PubMed ID: 26124057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.